This website uses cookies primarily for visitor analytics. Certain pages will ask you to fill in contact details to receive additional information. On these pages you have the option of having the site log your details for future visits. Indicating you want the site to remember your details will place a cookie on your device. To view our full cookie policy, please click here. You can also view it at any time by going to our Contact Us page.

Robots show healthy growth in the pharmaceutical industry

04 December 2023

Robots are bringing the same flexibility and efficiency improvements to the pharmaceutical industry as they have to more established automated production lines, such as automotive. Julian Ware, UK & Ireland Sales Manager of ABB Robotics, explains some of the benefits that are already well proven, as well as considering what the future might hold.

Faced with demand for everything from medication to vitamin supplements, pharmaceutical companies are looking for ways to transform their production processes. The aim is to become faster and more flexible, whilst still being able to meet strict regulatory requirements regarding product quality and safety

Robots are increasingly forming a major answer to these challenges, meeting needs at all stages, from R&D to logistics. These include primary packaging, dispensing, sorting, kit assembly, and machine tending. 

The COVID-19 pandemic gave a boost to the industry’s deployment of automated systems. Though the rate of adoption has now fallen slightly, there remains optimism that long-term trends are pointing the way to future healthy growth.

Statistics from the International Federation of Robotics (IFR) World Robotics 2023 report show that robotic deployments in the UK pharmaceutical sector grew by 21 percent between 2017 and 2022, indicating a growing awareness of the benefits that robotic automation can deliver. 

Read the full article in DPA's December issue

Contact Details and Archive...

Print this page | E-mail this page